Following the FDA approval of Truvada — the once-a-day pill that can drastically lower a person's risk of contracting HIV — Audie Cornish talks with Dr. Wafaa El-Sadr of Columbia University's Mailman School of Public Health. They examine the status of HIV prevention efforts in the U.S. today — what progress has been made and the challenges that still ahead. El-Sadr has worked on HIV/AIDS prevention and treatment since 1981.
Almost 90 percent of the target population – half in Port-au-Prince and the other half in a remote rural area – got fully protected against cholera. The results defy the forecasts of skeptics who said in advance of the campaign that it would be lucky to protect 60 percent of the target populations.
Years after chemical companies stop using BPA in baby bottles and sippy cups, the Food and Drug Administration announces a ban. But consumer groups say FDA should do more and ban BPA from all food containers.
Athletes at the London Olympics will be subjected to more testing for performance-enhancing drugs than at any other games. Just one positive test can ruin their chances at gold, but these elite athletes might not be the ones who have the most to lose.
Many organ donors are unaware they've also agreed to donate their veins, bones, skin and other tissue, which can be used not only to save a life, but also to help a cosmetic surgery patient. It's a $1 billion a year industry many know little about.
When you give to WAMU, your tax-deductible membership gift helps make possible award-winning programs such as Morning Edition, All Things Considered, The Diane Rehm Show, The Kojo Nnamdi Show, and other favorites.